abstract |
The present application relates to a liposomal ophthalmic composition for the treatment of dry eye conditions comprising cyclosporin and lipid. According to the present application, not only the solubility of the poorly soluble drug, cyclosporine, but also the therapeutic effect can be improved and the side effects such as irritation can be reduced. |